{"corpus_id":24183961,"paper_sha":"7074c5cf70ff6dd906be29b3695455b0111b2e2c","doi":"10.1002/ana.410440512","arxiv_id":null,"pmid":9818934,"pmcid":null,"mag_id":2022258023,"dblp_id":null,"acl_id":null,"title":"Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome","year":1998,"publication_date":"1998-11-01","venue":"Annals of Neurology","journal":{"name":"Annals of Neurology","pages":null,"volume":"44"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle","Study","ClinicalTrial"],"pubmed_pub_types":["Clinical Trial","Comparative Study","Journal Article","Randomized Controlled Trial","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Medicine"],"reference_count":54,"citation_count":935,"influential_citation_count":50,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Autoantibodies","mj":false,"qs":[{"q":"blood","mj":false,"ui":"Q000097"}],"ui":"D001323"},{"d":"Axons","mj":false,"qs":[{"q":"physiology","mj":false,"ui":"Q000502"}],"ui":"D001369"},{"d":"Demyelinating Diseases","mj":false,"qs":[{"q":"classification","mj":false,"ui":"Q000145"},{"q":"etiology","mj":false,"ui":"Q000209"},{"q":"physiopathology","mj":false,"ui":"Q000503"}],"ui":"D003711"},{"d":"Electrophysiology","mj":false,"qs":[{"q":"methods","mj":false,"ui":"Q000379"}],"ui":"D004594"},{"d":"Follow-Up Studies","mj":false,"ui":"D005500"},{"d":"G(M1) Ganglioside","mj":false,"qs":[{"q":"immunology","mj":false,"ui":"Q000276"}],"ui":"D005677"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Immunoglobulins, Intravenous","mj":false,"qs":[{"q":"therapeutic use","mj":true,"ui":"Q000627"}],"ui":"D016756"},{"d":"Motor Neurons","mj":false,"qs":[{"q":"physiology","mj":false,"ui":"Q000502"}],"ui":"D009046"},{"d":"Neural Conduction","mj":true,"ui":"D009431"},{"d":"Peripheral Nerves","mj":false,"qs":[{"q":"pathology","mj":false,"ui":"Q000473"},{"q":"physiopathology","mj":true,"ui":"Q000503"}],"ui":"D010525"},{"d":"Polyradiculoneuropathy","mj":false,"qs":[{"q":"classification","mj":true,"ui":"Q000145"},{"q":"physiopathology","mj":true,"ui":"Q000503"},{"q":"therapy","mj":false,"ui":"Q000628"}],"ui":"D011129"},{"d":"Time Factors","mj":false,"ui":"D013997"},{"d":"Treatment Outcome","mj":false,"ui":"D016896"}],"chemicals":[{"n":"Autoantibodies","ui":"D001323","reg":"0"},{"n":"Immunoglobulins, Intravenous","ui":"D016756","reg":"0"},{"n":"G(M1) Ganglioside","ui":"D005677","reg":"37758-47-7"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://orbi.uliege.be/bitstream/2268/114985/1/Wang%204.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/7074c5cf70ff6dd906be29b3695455b0111b2e2c","s2_open_access_license":"other-oa","s2_open_access_status":"GREEN","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"We performed electrophysiological and serological testing within 15 days of symptom onset on 369 patients with Guillain-Barré Syndrome (GBS) enrolled in a trial comparing plasma exchange, intravenous immunoglobulin, and both treatments. Patients were classified into five groups by motor nerve conduction criteria; 69% were demyelinating, 3% axonal, 3% inexcitable, 2% normal, and 23% equivocal. Six of 10 (60%) patients with axonal neurophysiology had had a preceding diarrheal illness compared with 71 of 359 (20%) in other groups. Antiganglioside GM1 antibodies were present in a higher proportion of patients with axonal physiology or inexcitable nerves than other patients. The number dead or unable to walk unaided at 48 weeks was greater in the group with initially inexcitable nerves (6 of 12, 50%) compared with the rest (52 of 357, 15%), but was not significantly different between the axonal (1 of 10, 10%) and demyelinating (44 of 254, 17%) groups. Sensory action potentials and clinical sensory examination were both normal in 53 of 342 (16%) patients, and these \"pure motor GBS\" patients were more likely than other GBS patients to have IgG antiganglioside GM1 antibodies and to have had preceding diarrhea but had a similar outcome. The axonal group was more likely than other groups to have normal sensory action potentials. The outcomes in response to the three treatments did not differ in any subgroup (including patients with pure motor GBS or preceding diarrhea) or any neurophysiological category.","claims":[{"public_id":"cl_70dad55b9be8de9a846c269741292f7a","status":"active","text":"Among 369 Guillain-Barré Syndrome patients tested within 15 days of symptom onset, motor nerve conduction criteria classified 69% as demyelinating, 3% as axonal, 3% as inexcitable, 2% as normal, and 23% as equivocal.","confidence":0.97,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_70dad55b9be8de9a846c269741292f7a"},{"public_id":"cl_99b70c03799e52fbec6cabcffd0170f4","status":"active","text":"Antiganglioside GM1 antibodies were present in a higher proportion of patients with axonal physiology or inexcitable nerves than in other patients.","confidence":0.94,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_99b70c03799e52fbec6cabcffd0170f4"},{"public_id":"cl_21fa4444cd1bcce986cfa08424dda716","status":"active","text":"Patients with initially inexcitable nerves had a greater rate of death or inability to walk unaided at 48 weeks than the rest of the cohort, while outcomes were not significantly different between axonal and demyelinating groups.","confidence":0.94,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_21fa4444cd1bcce986cfa08424dda716"},{"public_id":"cl_5c690ee857ab215440079790cfc630ab","status":"active","text":"Preceding diarrheal illness was more frequent in patients with axonal neurophysiology than in patients in the other neurophysiological groups.","confidence":0.95,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_5c690ee857ab215440079790cfc630ab"},{"public_id":"cl_3c21f5e1750838e35509f1d0af9a4f3c","status":"active","text":"Pure motor GBS patients were more likely than other Guillain-Barré Syndrome patients to have IgG antiganglioside GM1 antibodies and preceding diarrhea, but had a similar outcome.","confidence":0.93,"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/claims/cl_3c21f5e1750838e35509f1d0af9a4f3c"}],"concepts":[{"public_id":"co_0806423ad75ed62b6478b8e0826a9675","status":"active","name":"preceding diarrheal illness","description":"A diarrheal illness occurring before Guillain-Barré Syndrome symptom onset.","types":["clinical history"],"aliases":["preceding diarrhea"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_0806423ad75ed62b6478b8e0826a9675"},{"public_id":"co_4c7a95d38c9979fa50e49f471cfc24e8","status":"active","name":"neurophysiological category","description":"A patient grouping based on electrophysiological classification of Guillain-Barré Syndrome.","types":["classification category"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_4c7a95d38c9979fa50e49f471cfc24e8"},{"public_id":"co_4e8f2532504929bcf21dea10b630de19","status":"active","name":"demyelinating neurophysiology","description":"A motor nerve conduction category reflecting demyelinating features in Guillain-Barré Syndrome patients.","types":["neurophysiological category"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_4e8f2532504929bcf21dea10b630de19"},{"public_id":"co_5b39b8e18c73aecd85ca909afcf41b75","status":"active","name":"axonal neurophysiology","description":"A motor nerve conduction category reflecting axonal features in Guillain-Barré Syndrome patients.","types":["neurophysiological category"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_5b39b8e18c73aecd85ca909afcf41b75"},{"public_id":"co_90618cc1dba530e46a912db83a157ae0","status":"active","name":"antiganglioside GM1 antibodies","description":"Serological antibodies against ganglioside GM1 assessed in the enrolled patients.","types":["biomarker"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_90618cc1dba530e46a912db83a157ae0"},{"public_id":"co_96341430fda64170b1a6009d51e4a588","status":"active","name":"motor nerve conduction criteria","description":"Electrophysiological criteria used to classify patients into neurophysiological groups.","types":["classification criteria"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_96341430fda64170b1a6009d51e4a588"},{"public_id":"co_a5ea0996f9cbddbd57a2729cf8b80704","status":"active","name":"Guillain-Barré Syndrome","description":"A neurological syndrome represented by the 369 patients enrolled in the treatment trial.","types":["condition"],"aliases":["GBS"],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_a5ea0996f9cbddbd57a2729cf8b80704"},{"public_id":"co_a85d27d7bc338e56bfb4d786fd05d69f","status":"active","name":"IgG antiganglioside GM1 antibodies","description":"The IgG class of antibodies against ganglioside GM1 measured in Guillain-Barré Syndrome patients.","types":["biomarker"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_a85d27d7bc338e56bfb4d786fd05d69f"},{"public_id":"co_dc16a4600ee2b42ba23d70fd16d14d58","status":"active","name":"inexcitable nerves","description":"A neurophysiological category in which nerves were initially inexcitable during electrophysiological testing.","types":["neurophysiological category"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_dc16a4600ee2b42ba23d70fd16d14d58"},{"public_id":"co_df635a4f4ec12a98e42be3ea5746c1e5","status":"active","name":"pure motor GBS","description":"A Guillain-Barré Syndrome subgroup with normal sensory action potentials and normal clinical sensory examination.","types":["patient subgroup"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_df635a4f4ec12a98e42be3ea5746c1e5"},{"public_id":"co_e3d8f965948925f74d3ebaf69dcbb748","status":"active","name":"death or inability to walk unaided at 48 weeks","description":"A clinical outcome endpoint combining mortality and inability to walk independently 48 weeks after enrollment.","types":["clinical outcome"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_e3d8f965948925f74d3ebaf69dcbb748"},{"public_id":"co_edd5ae32fac10fd7bd545513e4b7f1e4","status":"active","name":"sensory action potentials","description":"Electrophysiological sensory nerve responses evaluated as part of patient classification.","types":["electrophysiological measure"],"aliases":[],"contributors":[{"id":136,"public_id":"3c2apqe3ut","public_label":"Anonymous (3c2apqe3ut)","roles":["extraction"],"url":"https://sah.borca.ai/u/3c2apqe3ut"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"url":"https://sah.borca.ai/concepts/co_edd5ae32fac10fd7bd545513e4b7f1e4"}],"external_ids":{"DOI":"10.1002/ana.410440512","ArXiv":null,"PubMed":9818934,"PubMedCentral":null,"MAG":2022258023,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://orbi.uliege.be/bitstream/2268/114985/1/Wang%204.pdf","landing_url":"https://www.semanticscholar.org/paper/7074c5cf70ff6dd906be29b3695455b0111b2e2c","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"other-oa","status":"GREEN","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631901,"paper_uid":"16f17eb8-b050-4c89-bac9-ca49166d7990","canonical_identity":{"paper_id":631901,"paper_uid":"16f17eb8-b050-4c89-bac9-ca49166d7990","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/24183961"}